MedPath

Developing a diagnostic method for pancreatic cancer at the very early stage

Not Applicable
Conditions
Intraductal papillary mucinous neoplasm (IPMN), Pancreatic cancer
Registration Number
JPRN-UMIN000017958
Lead Sponsor
Osaka City University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

The consent for registration is not understood

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Better diagnostic performance is obtained than existing tumor markers
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath